Amarantus Bioscience Holdings Inc (AMBS)

[Ahjon81]

$EMOR financial report

12. Subsequent Events.
On 1/02/2020 - Emerald gained exclusive worldwide development rights from Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS), to ESS, MANF and PhenoGuard FDA regulated therapeutics with Amarantus to receive Emerald preferred stock valued at a minimum of $66.6 million.” 33M shares of $EMOR will be issued to $AMBS